RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Obesity-associated nonalcoholic fatty liver disease (NAFLD) is characterized by excessive intrahepatic lipid accumulation. Despite the increasing prevalence of NAFLD and obesity, the pathogenesis of NAFLD has not yet been clearly elucidated. Prohibitin 1 (PHB1) is mainly expressed in the inner membrane of mitochondria and is known to play an important role in hepatocyte proliferation and lipid metabolism. In this study, we investigated how PHB1 affects lipid metabolism in murine hepatocytes. To reduce the expression of PHB1, Phb1 small interfering RNA was transfected into normal murine hepatocytes (AML12), and the cells were treated with the saturated fatty acid (SFA), palmitic acid (PA), for 24 h. When PHB1 was inhibited, the cell viability decreased by ∼20%, and it was found that it diminished further after PA treatment in both control and peroxisome proliferator-activated receptor gamma (Ppar-γ) knockdown cell groups. Examination of the mRNA expression levels of key enzymes involved in lipid metabolism revealed that PHB1 led to increased stearoyl-coenzyme A desaturase-1 (Scd1) mRNA levels, which leads to an increase in the synthesis of triglycerides (TGs). It also activates the endoplasmic reticulum (ER) stress response through upregulating C/EBP homologous protein (Chop) mRNA levels. PPAR-γ, which has been reported to be upregulated in NAFLD patients, also showed elevated expression. The expression of carnitine palmitoyltransferase 1A, which is involved in the conversion of excess intracellular SFA to fatty acid by catabolism, was downregulated in the PHB1-deficient group. Furthermore, TG synthesis was further promoted by a marked increase in SCD1 mRNA levels, which was further exacerbated by elevated Chop mRNA levels and Ppar-γ disruption. Taken together, PHB1 deficiency led to altered lipid metabolism, resulting in the increased intracellular lipid accumulation and ER stress. These cytotoxic effects were shown to be further exacerbated by excessive PA treatment.

참고문헌 (Reference)

1 Judith Storch, "The fatty acid transport function of fatty acid-binding proteins" Elsevier BV 1486 (1486): 28-44, 2000

2 Makoto Miyazaki, "The Biosynthesis of Hepatic Cholesterol Esters and Triglycerides Is Impaired in Mice with a Disruption of the Gene for Stearoyl-CoA Desaturase 1" Elsevier BV 275 (275): 30132-30138, 2000

3 Dong Wang, "Saturated Fatty Acids Promote Endoplasmic Reticulum Stress and Liver Injury in Rats with Hepatic Steatosis" The Endocrine Society 147 (147): 943-951, 2006

4 Serge Hardy, "Saturated Fatty Acid-induced Apoptosis in MDA-MB-231 Breast Cancer Cells" Elsevier BV 278 (278): 31861-31870, 2003

5 Dobbins RL, "Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats" 50 (50): 123-130, 2001

6 S R Ande, "Prohibitin has an important role in adipocyte differentiation" Springer Science and Business Media LLC 36 (36): 1236-1244, 2011

7 Virginia Sánchez-Quiles, "Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: Molecular mechanisms and functional implications" Wiley 10 (10): 1609-1620, 2010

8 Sheng Wang, "Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression" Springer Science and Business Media LLC 21 (21): 8388-8396, 2002

9 최장원 ; 윤종원, "Prohibitin Deficiency Causes Opposing Lipid Metabolism between 3T3-L1 Adipocytes and Clone 9 Hepatocytes" 한국생물공학회 21 (21): 294-298, 2016

10 Yong Zhang, "Palmitic and linoleic acids induce ER stress and apoptosis in hepatoma cells" Springer Science and Business Media LLC 5 (5): 1-, 2012